LIXTE BIOTECHNOLOGY HLDGS IN
LIXT·539319301·US·Common Stock·Healthcare - Biotechnology-13D/G
LIXT (LIXTE BIOTECHNOLOGY HLDGS IN) is held by 12 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($4.1M), SCOTIA CAPITAL INC. ($2.1M), GEODE CAPITAL MANAGEMENT, LLC ($1.1M). Net institutional sentiment: Mixed.
12
Holders
$9.6M
Total Value
67% (15)
Consensus
10 buying - 5 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 9, 2026 · Insiders Jul 2, 2026 · Activists Jun 9, 2026 · Congress none
InsiderPWPrimus Guy WarrenVest 15K shJul 1, 2026
InsiderSDSawyer Jason DavidVest 40K shJul 1, 2026
InsiderPGPursglove Geordan GarrettVest 350K shJul 1, 2026
Checking access…
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
416 holders · $299.1B
415 holders · $877.5B
400 holders · $151.4B
397 holders · $414.1B
394 holders · $97.5B
393 holders · $111.5B
390 holders · $230.1B
385 holders · $302.9B
385 holders · $51.8B
382 holders · $113.8B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer